Oliver Luxxe Assets’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.55M Buy
71,240
+935
+1% +$20.3K 0.28% 117
2025
Q1
$1.7M Sell
70,305
-32,970
-32% -$800K 0.32% 111
2024
Q4
$2.12M Buy
103,275
+69,250
+204% +$1.42M 0.19% 137
2024
Q3
$676K Buy
+34,025
New +$676K 0.12% 148